Heart Force Medical Inc.

Heart Force Medical Inc.

September 09, 2009 14:19 ET

Heart Force Medical Inc. Appoints Chief Business Officer

VANCOUVER, BRITISH COLUMBIA--(Marketwire - Sept. 9, 2009) - Heart Force Medical Inc., a Vancouver-based company that is developing a non-invasive cardiac performance monitor, announced today that it has appointed Tom Walker as its Chief Business Officer. Tom has extensive North American and international medical device experience, holding senior positions with Eli Lilly, Cardinal Health and AGFA HealthCare. Most recently he was President & CEO of a life science start-up venture in Ontario. The Company was recognized as one of Canada's Top 10 Emerging Life Science Companies for 2007/2008.

"Tom came to us serendipitously. He recently relocated to Vancouver after completing an M&A assignment in Ontario. His previous experience in both large and small healthcare companies provides Heart Force with substantial breadth and depth, and considerably enriches our executive team," said Dr. Geoff Houlton, President and CEO. "Tom's sales, marketing and business development skills will be a tremendous addition to Heart Force as we develop and implement our strategies that will lead to our future success in the global medical device arena."

"With its recent FDA approval, Heart Force is ideally positioned to focus on optimizing its growth into the global healthcare market," said Tom Walker. "I am very pleased to join this strong team which is dedicated to improving the assessment of cardiac performance. The commercialization of the dBG 300 Digital Ballistocardiograph is certain to have a significant impact on patient care."

About Heart Force

Heart Force Medical Inc. (HFM) is a private company. In June 2009 HFM was the winner of the BC Technology Impact Association Award for most promising pre-commercial technology. It has invented and has patents pending for the digital Ballistocardiograph (dBG™). The dBG™ is a recording of the movement of the heart during each cardiac cycle (heart beat). The movement (acceleration and force) is sensed by an accelerometer aligned to the three principal axes and displayed on a computer screen using HFM proprietary software. Preliminary evaluation has determined that a 10-30 second recording of the dBG waveform is sufficient for a detailed analysis of cardiac performance. The Heart Force dBG 300 device is a standalone, portable unit and contains sophisticated digital sensors and proprietary software.

Contact Information